XML 47 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Operating activities:      
Net income (loss) $ 3,612 $ 946 $ (1,451)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation, depletion and amortization 1,753 2,066 2,316
Impairments 7 60 144
Exploratory dry well costs and unproved property impairments 101 125 159
Net (gain) loss on disposal of assets 38 19 (9)
Loss on early extinguishment of debt 0 121 28
Deferred income taxes (17) (27) (22)
Unrealized (gain) loss on derivative instruments, net (18) (16) 27
Pension and other post retirement benefits, net (35) (31) (43)
Stock-based compensation 38 40 57
Equity method investments, net (139) (76) 210
Changes in:      
Current receivables 9 (389) 367
Inventories (45) (1) (4)
Current accounts payable and accrued liabilities 101 369 (381)
Other current assets and liabilities (47) 46 75
All other operating, net 70 (13) 0
Net cash provided by operating activities 5,428 3,239 1,473
Investing activities:      
Additions to property, plant and equipment (1,450) (1,046) (1,343)
Additions to other assets 0 0 15
Acquisitions, net of cash acquired (3,177) (47) (1)
Disposal of assets, net of cash transferred to the buyer 11 22 18
Equity method investments - return of capital 12 61 7
All other investing, net (1) 0 1
Net cash used in investing activities (4,605) (1,010) (1,303)
Financing activities:      
Borrowings 1,500 0 400
Proceeds from revolving credit facility 450 0 0
Debt repayments (35) (1,400) (500)
Debt extinguishment costs 0 (117) (27)
Shares repurchased under buyback programs (2,754) (724) (85)
Dividends paid (220) (141) (64)
Purchases of shares for tax withholding obligations (22) (10) (7)
All other financing, net 12 1 (3)
Net cash used in financing activities (1,069) (2,391) (286)
Net increase (decrease) in cash and cash equivalents (246) (162) (116)
Cash and cash equivalents at beginning of period 580 742 858
Cash and cash equivalents at end of period $ 334 $ 580 $ 742